You have free access to this content

Hepatology

Cover image for Hepatology

April 2010

Volume 51, Issue 4

Pages 1095–1478

  1. Master's Perspective

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Rapid Communication
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    1. You have free access to this content
  2. Editorials

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Rapid Communication
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
    4. You have free access to this content
    5. You have free access to this content
  3. Viral Hepatitis

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Rapid Communication
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    1. You have free access to this content
      Twelve weeks posttreatment follow-up is as relevant as 24 weeks to determine the sustained virologic response in patients with hepatitis C virus receiving pegylated interferon and ribavirin (pages 1122–1126)

      Michelle Martinot-Peignoux, Christiane Stern, Sarah Maylin, Marie-Pierre Ripault, Nathalie Boyer, Laurence Leclere, Corinne Castelnau, Nathalie Giuily, Ahmed El Ray, Ana-Carolina Cardoso, Rami Moucari, Tarik Asselah and Patrick Marcellin

      Version of Record online: 30 NOV 2009 | DOI: 10.1002/hep.23444

    2. You have free access to this content
      Cleavage of mitochondrial antiviral signaling protein in the liver of patients with chronic hepatitis C correlates with a reduced activation of the endogenous interferon system (pages 1127–1136)

      Pantxika Bellecave, Magdalena Sarasin-Filipowicz, Olivier Donzé, Audrey Kennel, Jérôme Gouttenoire, Etienne Meylan, Luigi Terracciano, Jürg Tschopp, Christoph Sarrazin, Thomas Berg, Darius Moradpour and Markus H. Heim

      Version of Record online: 13 NOV 2009 | DOI: 10.1002/hep.23426

    3. You have free access to this content
      Effectiveness of hepatitis C treatment with pegylated interferon and ribavirin in urban minority patients (pages 1137–1143)

      Paul Feuerstadt, Ari L. Bunim, Heriberto Garcia, Jordan J. Karlitz, Hatef Massoumi, Amar J. Thosani, Andrew Pellecchia, Allan W. Wolkoff, Paul J. Gaglio and John F. Reinus

      Version of Record online: 13 NOV 2009 | DOI: 10.1002/hep.23429

    4. You have free access to this content
      Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2–CD81–Claudin-1 associations (pages 1144–1157)

      Sophie E. Krieger, Mirjam B. Zeisel, Christopher Davis, Christine Thumann, Helen J. Harris, Eva K. Schnober, Christopher Mee, Eric Soulier, Cathy Royer, Mélanie Lambotin, Fritz Grunert, Viet Loan Dao Thi, Marlène Dreux, François-Loïc Cosset, Jane A. McKeating, Catherine Schuster and Thomas F. Baumert

      Version of Record online: 30 NOV 2009 | DOI: 10.1002/hep.23445

    5. You have free access to this content
      Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C (pages 1158–1167)

      Salvatore Petta, Calogero Cammà, Concetta Scazzone, Claudio Tripodo, Vito Di Marco, Antonino Bono, Daniela Cabibi, Giusalba Licata, Rossana Porcasi, Giulio Marchesini and Antonio Craxí

      Version of Record online: 4 DEC 2009 | DOI: 10.1002/hep.23489

    6. You have full text access to this OnlineOpen article
      Consistent beneficial effects of killer cell immunoglobulin-like receptor 2DL3 and group 1 human leukocyte antigen-C following exposure to hepatitis C virus (pages 1168–1175)

      Susanne Knapp, Usama Warshow, Doha Hegazy, Louise Brackenbury, I. Neil Guha, Andrew Fowell, Ann-Margaret Little, Graeme J. Alexander, William M.C. Rosenberg, Matthew E. Cramp and Salim I. Khakoo

      Version of Record online: 30 NOV 2009 | DOI: 10.1002/hep.23477

    7. You have free access to this content
    8. You have free access to this content
      Efficacy of entecavir in chronic hepatitis B patients with mildly elevated alanine aminotransferase and biopsy-proven histological damage (pages 1185–1189)

      I-Chin Wu, Ching-Lung Lai, Steven-Huy Bui Han, Kwang-Hyup Han, Stuart C. Gordon, You-Chen Chao, Chee-Kiat Tan, William Sievert, Tawesak Tanwandee, Dong Xu, Boon-Leong Neo and Ting-Tsung Chang

      Version of Record online: 9 NOV 2009 | DOI: 10.1002/hep.23424

  4. Steatohepatitis/Metabolic Liver Disease

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Rapid Communication
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    1. You have free access to this content
      Functional proteomic analysis of nonalcoholic fatty liver disease in rat models: Enoyl–coenzyme a hydratase down-regulation exacerbates hepatic steatosis (pages 1190–1199)

      Xuequn Zhang, Juntao Yang, Yuanbiao Guo, Hua Ye, Chaohui Yu, Chengfu Xu, Lei Xu, Songfeng Wu, Wei Sun, Hangdong Wei, Xue Gao, Yunping Zhu, Xiaohong Qian, Ying Jiang, Youming Li and Fuchu He

      Version of Record online: 4 DEC 2009 | DOI: 10.1002/hep.23486

    2. You have free access to this content
      Adeno-associated virus gene repair corrects a mouse model of hereditary tyrosinemia in vivo (pages 1200–1208)

      Nicole K. Paulk, Karsten Wursthorn, Zhongya Wang, Milton J. Finegold, Mark A. Kay and Markus Grompe

      Version of Record online: 30 NOV 2009 | DOI: 10.1002/hep.23481

    3. You have free access to this content
      Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease (pages 1209–1217)

      Luca Valenti, Ahmad Al-Serri, Ann K. Daly, Enrico Galmozzi, Raffaela Rametta, Paola Dongiovanni, Valerio Nobili, Enrico Mozzi, Giancarlo Roviaro, Ester Vanni, Elisabetta Bugianesi, Marco Maggioni, Anna Ludovica Fracanzani, Silvia Fargion and Christopher P. Day

      Version of Record online: 23 FEB 2010 | DOI: 10.1002/hep.23622

  5. Hepatobiliary Malignancies

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Rapid Communication
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    1. You have free access to this content
      Targeting mitogen-activated protein kinase kinase with the inhibitor PD0325901 decreases hepatocellular carcinoma growth in vitro and in mouse model systems (pages 1218–1225)

      Matthew Hennig, Michele T. Yip-Schneider, Sabrina Wentz, Huangbing Wu, S. K. Hekmatyar, Patrick Klein, Navin Bansal and C. Max Schmidt

      Version of Record online: 30 NOV 2009 | DOI: 10.1002/hep.23470

    2. You have free access to this content
      Hepatocyte-specific deletion of the antiapoptotic protein myeloid cell leukemia-1 triggers proliferation and hepatocarcinogenesis in mice (pages 1226–1236)

      Achim Weber, Regina Boger, Binje Vick, Toni Urbanik, Johannes Haybaeck, Stefan Zoller, Andreas Teufel, Peter H. Krammer, Joseph T. Opferman, Peter R. Galle, Marcus Schuchmann, Mathias Heikenwalder and Henning Schulze-Bergkamen

      Version of Record online: 30 NOV 2009 | DOI: 10.1002/hep.23479

    3. You have free access to this content
      Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma (pages 1237–1243)

      Christian Toso, Shaheed Merani, David L. Bigam, A.M. James Shapiro and Norman M. Kneteman

      Version of Record online: 13 NOV 2009 | DOI: 10.1002/hep.23437

    4. You have free access to this content
      Serotonin promotes tumor growth in human hepatocellular cancer (pages 1244–1254)

      Christopher Soll, Jae Hwi Jang, Marc-Oliver Riener, Wolfgang Moritz, Peter Johannes Wild, Rolf Graf and Pierre-Alain Clavien

      Version of Record online: 20 NOV 2009 | DOI: 10.1002/hep.23441

    5. You have free access to this content
      Overexpression of eukaryotic initiation factor 5A2 enhances cell motility and promotes tumor metastasis in hepatocellular carcinoma (pages 1255–1263)

      Dong-Jiang Tang, Sui-Sui Dong, Ning-Fang Ma, Dan Xie, Leilei Chen, Li Fu, Sze Hang Lau, Yan Li, Yan Li and Xin-Yuan Guan

      Version of Record online: 30 NOV 2009 | DOI: 10.1002/hep.23451

    6. You have free access to this content
    7. You have free access to this content
      A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma (pages 1274–1283)

      Giuseppe Cabibbo, Marco Enea, Massimo Attanasio, Jordi Bruix, Antonio Craxì and Calogero Cammà

      Version of Record online: 4 DEC 2009 | DOI: 10.1002/hep.23485

    8. You have free access to this content
  6. Autoimmune, Cholestatic and Biliary Disease

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Rapid Communication
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    1. You have free access to this content
    2. You have free access to this content
      The predictors of the presence of varices in patients with primary sclerosing cholangitis (pages 1302–1310)

      Sombat Treeprasertsuk, Kris V. Kowdley, Velimir A. C. Luketic, M. Edwyn Harrison, Timothy McCashland, Alex S. Befeler, Denise Harnois, Roberta Jorgensen, Jan Petz, Jill Keach, Jeff Schmoll, Tanya Hoskin, Prabin Thapa, Felicity Enders and Keith D. Lindor

      Version of Record online: 13 NOV 2009 | DOI: 10.1002/hep.23432

    3. You have free access to this content
      HFE C282Y homozygotes are at increased risk of breast and colorectal cancer (pages 1311–1318)

      Nicholas J. Osborne, Lyle C. Gurrin, Katrina J. Allen, Clare C. Constantine, Martin B. Delatycki, Christine E. McLaren, Dorota M. Gertig, Gregory J. Anderson, Melissa C. Southey, John K. Olynyk, Lawrie W. Powell, John L. Hopper, Graham G. Giles and Dallas R. English

      Version of Record online: 30 NOV 2009 | DOI: 10.1002/hep.23448

  7. Liver Failure/Cirrhosis/Portal Hypertension

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Rapid Communication
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    1. You have free access to this content
      Disruption of the growth hormone—Signal transducer and activator of transcription 5—Insulinlike growth factor 1 axis severely aggravates liver fibrosis in a mouse model of cholestasis (pages 1319–1326)

      Leander Blaas, Jan-Wilhelm Kornfeld, Daniel Schramek, Monica Musteanu, Gernot Zollner, Judith Gumhold, Franziska van Zijl, Doris Schneller, Harald Esterbauer, Gerda Egger, Markus Mair, Lukas Kenner, Wolfgang Mikulits, Robert Eferl, Richard Moriggl, Josef Penninger, Michael Trauner and Emilio Casanova

      Version of Record online: 30 NOV 2009 | DOI: 10.1002/hep.23469

    2. You have free access to this content
      Nucleotide-binding oligomerization domain containing 2 (NOD2) variants are genetic risk factors for death and spontaneous bacterial peritonitis in liver cirrhosis (pages 1327–1333)

      Beate Appenrodt, Frank Grünhage, Martin G. Gentemann, Lydia Thyssen, Tilman Sauerbruch and Frank Lammert

      Version of Record online: 20 NOV 2009 | DOI: 10.1002/hep.23440

  8. Liver Injury/Regeneration

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Rapid Communication
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    1. You have free access to this content
      Down-regulation of the LXR transcriptome provides the requisite cholesterol levels to proliferating hepatocytes (pages 1334–1344)

      Giuseppe Lo Sasso, Nicola Celli, Mariaelena Caboni, Stefania Murzilli, Lorena Salvatore, Annalisa Morgano, Michele Vacca, Tommaso Pagliani, Paolo Parini and Antonio Moschetta

      Version of Record online: 13 NOV 2009 | DOI: 10.1002/hep.23436

    2. You have free access to this content
      CXC chemokine ligand 4 (Cxcl4) is a platelet-derived mediator of experimental liver fibrosis (pages 1345–1353)

      Mirko Moreno Zaldivar, Katrin Pauels, Philipp von Hundelshausen, Marie-Luise Berres, Petra Schmitz, Jörg Bornemann, M. Anna Kowalska, Nikolaus Gassler, Konrad L. Streetz, Ralf Weiskirchen, Christian Trautwein, Christian Weber and Hermann E. Wasmuth

      Version of Record online: 13 NOV 2009 | DOI: 10.1002/hep.23435

    3. You have free access to this content
      Interplay of hepatic and myeloid signal transducer and activator of transcription 3 in facilitating liver regeneration via tempering innate immunity (pages 1354–1362)

      Hua Wang, Ogyi Park, Fouad Lafdil, Kezhen Shen, Norio Horiguchi, Shi Yin, Xin-Yuan Fu, George Kunos and Bin Gao

      Version of Record online: 13 NOV 2009 | DOI: 10.1002/hep.23430

    4. You have free access to this content
      The emerging role of T cell immunoglobulin mucin-1 in the mechanism of liver ischemia and reperfusion injury in the mouse (pages 1363–1372)

      Yoichiro Uchida, Bibo Ke, Maria Cecilia S. Freitas, Haofeng Ji, Danyun Zhao, Elizabeth R. Benjamin, Nader Najafian, Hideo Yagita, Hisaya Akiba, Ronald W. Busuttil and Jerzy W. Kupiec-Weglinski

      Version of Record online: 30 NOV 2009 | DOI: 10.1002/hep.23442

    5. You have free access to this content
      Role of transforming growth factor β signaling and expansion of progenitor cells in regenerating liver (pages 1373–1382)

      Arun Thenappan, Ying Li, Krit Kitisin, Asif Rashid, Kirti Shetty, Lynt Johnson and Lopa Mishra

      Version of Record online: 30 NOV 2009 | DOI: 10.1002/hep.23449

  9. Liver Biology/Pathobiology

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Rapid Communication
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    1. You have free access to this content
      Mitogen-inducible gene-6 is a negative regulator of epidermal growth factor receptor signaling in hepatocytes and human hepatocellular carcinoma (pages 1383–1390)

      Markus Reschke, Ingvar Ferby, Ewa Stepniak, Nina Seitzer, David Horst, Erwin F. Wagner and Axel Ullrich

      Version of Record online: 13 NOV 2009 | DOI: 10.1002/hep.23428

    2. You have free access to this content
      Notch signaling regulates formation of the three-dimensional architecture of intrahepatic bile ducts in mice (pages 1391–1400)

      Erin E. Sparks, Kari A. Huppert, Melanie A. Brown, M. Kay Washington and Stacey S. Huppert

      Version of Record online: 13 NOV 2009 | DOI: 10.1002/hep.23431

    3. You have free access to this content
      Progenitor-derived hepatocellular carcinoma model in the rat (pages 1401–1409)

      Jesper B. Andersen, Roberto Loi, Andrea Perra, Valentina M. Factor, Giovanna M. Ledda-Columbano, Amedeo Columbano and Snorri S. Thorgeirsson

      Version of Record online: 4 DEC 2009 | DOI: 10.1002/hep.23488

    4. You have free access to this content
      Genome-wide tissue-specific farnesoid X receptor binding in mouse liver and intestine (pages 1410–1419)

      Ann M. Thomas, Steven N. Hart, Bo Kong, Jianwen Fang, Xiao-bo Zhong and Grace L. Guo

      Version of Record online: 30 NOV 2009 | DOI: 10.1002/hep.23450

      Corrected by:

      Correction: Erratum: Genome-wide tissue-specific farnesoid X receptor binding in mouse liver and intestine

      Vol. 52, Issue 1, 402, Version of Record online: 14 MAY 2010

    5. You have free access to this content
      The anti-inflammatory effects of adiponectin are mediated via a heme oxygenase-1–dependent pathway in rat Kupffer cells (pages 1420–1429)

      Palash Mandal, Pil-Hoon Park, Megan R. McMullen, Brian T. Pratt and Laura E. Nagy

      Version of Record online: 13 NOV 2009 | DOI: 10.1002/hep.23427

  10. Rapid Communication

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Rapid Communication
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    1. You have free access to this content
      Bioluminescence imaging allows measuring CD8 T cell function in the liver (pages 1430–1437)

      Dirk Stabenow, Marianne Frings, Christina Trück, Katja Gärtner, Irmgard Förster, Christian Kurts, Thomas Tüting, Margarete Odenthal, Hans-Peter Dienes, Karin Cederbrant, Ulrike Protzer and Percy A. Knolle

      Version of Record online: 3 FEB 2010 | DOI: 10.1002/hep.23575

  11. Reviews

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Rapid Communication
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    1. You have free access to this content
      Portal fibroblasts: Underappreciated mediators of biliary fibrosis (pages 1438–1444)

      Jonathan A. Dranoff and Rebecca G. Wells

      Version of Record online: 23 OCT 2009 | DOI: 10.1002/hep.23405

    2. You have free access to this content
      Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis (pages 1445–1449)

      Guadalupe Garcia-Tsao, Scott Friedman, John Iredale and Massimo Pinzani

      Version of Record online: 30 NOV 2009 | DOI: 10.1002/hep.23478

    3. You have free access to this content
  12. Hepatology Elsewhere

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Rapid Communication
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    1. You have free access to this content
      Antagonizing MicroRNA-122 and treatment of hepatitis C virus infection (pages 1461–1463)

      Sébastien Pfeffer and Thomas F. Baumert

      Version of Record online: 29 MAR 2010 | DOI: 10.1002/hep.23573

    2. You have free access to this content
  13. Image of the Month

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Rapid Communication
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    1. You have free access to this content
      Madelung's disease and alcoholic liver disorder (pages 1466–1467)

      Mei-Ju Ko and Hsien-Ching Chiu

      Version of Record online: 30 NOV 2009 | DOI: 10.1002/hep.23480

  14. Correspondence

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Rapid Communication
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    1. You have free access to this content
      No contribution to liver fibrosis, but possible carcinogenesis? (pages 1468–1469)

      Da-Wei Zhang and Huijie Bian

      Version of Record online: 19 FEB 2010 | DOI: 10.1002/hep.23604

    2. You have free access to this content
      Reply (page 1469)

      Kojiro Taura, Kouichi Miura and David Brenner

      Version of Record online: 19 FEB 2010 | DOI: 10.1002/hep.23609

    3. You have free access to this content
      Importance of the compensatory anti-inflammatory response following severe sepsis on cirrhosis (pages 1469–1470)

      Philip A. Berry, Charalambos G. Antoniades and Julia Wendon

      Version of Record online: 28 JAN 2010 | DOI: 10.1002/hep.23552

    4. You have free access to this content
      Reply (page 1470)

      Thierry Gustot and Richard Moreau

      Version of Record online: 19 FEB 2010 | DOI: 10.1002/hep.23610

    5. You have free access to this content
      A missing link in the puzzle: Brown adipose tissue (pages 1470–1471)

      Tugrul Purnak, Ersan Ozaslan, Cumali Efe and Hasan Sevimler

      Version of Record online: 28 JAN 2010 | DOI: 10.1002/hep.23559

    6. You have free access to this content
      Reply (pages 1471–1472)

      Elisa Fabbrini, Shelby Sullivan and Samuel Klein

      Version of Record online: 29 MAR 2010 | DOI: 10.1002/hep.23621

    7. You have free access to this content
      The link between hepatosteatosis and cells of the immune system (page 1472)

      Anna Alisi, Nadia Panera and Valerio Nobili

      Version of Record online: 28 JAN 2010 | DOI: 10.1002/hep.23563

    8. You have free access to this content
      Reply (pages 1472–1473)

      Ian N. Hines

      Version of Record online: 1 MAR 2010 | DOI: 10.1002/hep.23634

    9. You have free access to this content
      Non-HFE–related hemochromatosis: The role of genetic factors (pages 1473–1474)

      Agustin Castiella, Eva Zapata, Pedro Otazua, Leire Zubiaurre and Javier Fernandez

      Version of Record online: 19 FEB 2010 | DOI: 10.1002/hep.23603

    10. You have free access to this content
      Reply (page 1474)

      Anna Ludovica Fracanzani, Alberto Piperno, Luca Valenti and Silvia Fargion

      Version of Record online: 1 MAR 2010 | DOI: 10.1002/hep.23632

    11. You have free access to this content
      Matrix metalloproteinase-9 in fulminant hepatic failure (pages 1475–1476)

      Lluis Palenzuela, Antoni Mas, Joan Montaner and Juan Cordoba

      Version of Record online: 28 JAN 2010 | DOI: 10.1002/hep.23558

    12. You have free access to this content
      Reply (page 1476)

      Justin H. Nguyen

      Version of Record online: 1 MAR 2010 | DOI: 10.1002/hep.23638

    13. You have free access to this content
    14. You have free access to this content
      Reply (pages 1477–1478)

      Ina Bergheim and Astrid Spruss

      Version of Record online: 1 MAR 2010 | DOI: 10.1002/hep.23636

SEARCH

SEARCH BY CITATION